Annabel Samimy
Stock Analyst at Stifel
(4.29)
# 339
Out of 4,784 analysts
59
Total ratings
44.44%
Success rate
26.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Annabel Samimy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $27.76 | +62.10% | 1 | Mar 26, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $50 | $19.94 | +150.75% | 1 | Jan 8, 2025 | |
| ALT Altimmune | Initiates: Buy | $18 | $5.57 | +223.16% | 1 | Jan 8, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $17 | $3.04 | +458.59% | 4 | Nov 22, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $40 | $7.41 | +439.81% | 1 | Oct 8, 2024 | |
| KMDA Kamada | Initiates: Buy | $18 | $6.83 | +163.54% | 1 | Jul 3, 2024 | |
| PHAT Phathom Pharmaceuticals | Initiates: Buy | $24 | $6.69 | +258.74% | 1 | May 3, 2024 | |
| RGNX REGENXBIO | Maintains: Buy | $40 | $7.91 | +405.69% | 2 | Apr 12, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $80 | $26.13 | +206.16% | 6 | Mar 15, 2024 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $225 → $230 | $126.40 | +81.96% | 8 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 → $25 | $12.24 | +104.25% | 1 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $19.40 | +80.41% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $65 | $24.28 | +167.71% | 3 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $336 | $5.38 | +6,145.35% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $28 → $11 | $0.33 | +3,253.66% | 4 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $15.00 | +200.00% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $1.03 | +676.70% | 1 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $1.34 | +1,691.04% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $20 | $29.08 | -31.22% | 1 | Apr 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $750 | $1.05 | +71,328.57% | 3 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $24 | $32.42 | -25.97% | 7 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $21 | $0.81 | +2,505.46% | 6 | Sep 18, 2019 |
Palvella Therapeutics
Mar 26, 2025
Initiates: Buy
Price Target: $45
Current: $27.76
Upside: +62.10%
Structure Therapeutics
Jan 8, 2025
Initiates: Buy
Price Target: $50
Current: $19.94
Upside: +150.75%
Altimmune
Jan 8, 2025
Initiates: Buy
Price Target: $18
Current: $5.57
Upside: +223.16%
Inventiva
Nov 22, 2024
Maintains: Buy
Price Target: $20 → $17
Current: $3.04
Upside: +458.59%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $40
Current: $7.41
Upside: +439.81%
Kamada
Jul 3, 2024
Initiates: Buy
Price Target: $18
Current: $6.83
Upside: +163.54%
Phathom Pharmaceuticals
May 3, 2024
Initiates: Buy
Price Target: $24
Current: $6.69
Upside: +258.74%
REGENXBIO
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $7.91
Upside: +405.69%
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $80
Current: $26.13
Upside: +206.16%
Jazz Pharmaceuticals
Mar 15, 2024
Maintains: Buy
Price Target: $225 → $230
Current: $126.40
Upside: +81.96%
Mar 8, 2024
Reiterates: Buy
Price Target: $23 → $25
Current: $12.24
Upside: +104.25%
Oct 5, 2023
Initiates: Buy
Price Target: $35
Current: $19.40
Upside: +80.41%
Aug 29, 2023
Maintains: Buy
Price Target: $60 → $65
Current: $24.28
Upside: +167.71%
Jun 27, 2023
Reiterates: Buy
Price Target: $336
Current: $5.38
Upside: +6,145.35%
Jun 26, 2023
Downgrades: Hold
Price Target: $28 → $11
Current: $0.33
Upside: +3,253.66%
Mar 7, 2023
Initiates: Buy
Price Target: $45
Current: $15.00
Upside: +200.00%
Nov 10, 2022
Upgrades: Buy
Price Target: $8
Current: $1.03
Upside: +676.70%
Aug 24, 2021
Initiates: Buy
Price Target: $24
Current: $1.34
Upside: +1,691.04%
Apr 24, 2020
Initiates: Hold
Price Target: $20
Current: $29.08
Upside: -31.22%
Apr 16, 2020
Maintains: Buy
Price Target: $700 → $750
Current: $1.05
Upside: +71,328.57%
Apr 16, 2020
Maintains: Hold
Price Target: $25 → $24
Current: $32.42
Upside: -25.97%
Sep 18, 2019
Maintains: Hold
Price Target: $15 → $21
Current: $0.81
Upside: +2,505.46%